We are live on ! Find out more
BTCY

Biotricity, Inc. Common Stock
BTCY

Delisted

BTCY was delisted on the 2nd of August, 2024.

Back to rankings

15 hedge funds and large institutions have $564K invested in Biotricity, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
+$178K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$98.8K
3
MFG
Magnus Financial Group
New York
+$57.5K
4
OSNBOA
Old Second National Bank of Aurora
Illinois
+$46.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$38.9K

Top Sellers

No sellers this quarter

BTCY Hedge Fund Activity: Q3 2021 in Review

15 of the 5,643 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q3 2021, worth a combined $564K.

Buyers outnumbered sellers: 15 funds opened new BTCY positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was HighTower Advisors, opening a new position worth an estimated $178K.

  • 15 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $564K of Biotricity, Inc. Common Stock stock for Q3 2021.
  • 15 funds opened new Biotricity, Inc. Common Stock positions in Q3 2021 and 0 closed out, a net change of +15 holders.
  • The largest Biotricity, Inc. Common Stock buyer in Q3 2021 was HighTower Advisors, an estimated $178K added.

Based on aggregated 13F filings for Q3 2021.